Celltrion Achieves Milestone in Eco-Friendly Packaging, Boosts ESG Efforts with 81% Conversion Rate

Celltrion, a leading biopharmaceutical company, has made significant strides in its environmental, social, and governance (ESG) management, with a notable achievement of converting 81% of its packaging to eco-friendly certified products in 2024. This milestone is a testament to the company's commitment to reducing its environmental footprint and promoting sustainability. As detailed in its 2025-2026 Sustainability Report, Celltrion has been consistently working towards strengthening its ESG management, with a focus on eco-friendly packaging, open innovation, and corporate governance.

The company's efforts in eco-friendly packaging are particularly noteworthy, with a 10 percentage point increase in conversion rate compared to the previous year. This achievement is a result of Celltrion's gradual conversion of packaging materials, including cartons, leaflets, and tertiary packaging boxes, to eco-friendly certified products. Additionally, the company has raised its waste recycling rate to 71% and strengthened its resource circulation management by entrusting all general waste generated at Plant 1 to specialized recycling companies.

In the social sector, Celltrion has been actively engaged in open innovation activities, driving research and development innovation and expanding the foundation for collaboration within the bio industry. The company has contributed to the growth of Korea's bio ecosystem by selecting four final companies for the fourth cohort of the '2026 Seoul Bio Hub-Celltrion Open Innovation Program.' Furthermore, Celltrion has been involved in social contribution activities, including blood cancer patient support through the donation running campaign 'Kkumkkureon' and the employee-participation in-house sharing bazaar 'Celeb Market.'

In terms of governance, Celltrion has strengthened the reliability and transparency of its corporate operations, with a focus on information protection. The company has become the first among Korean bio companies to simultaneously obtain 'Global CBPR' certification and 'APEC CBPR' certification, a global personal information protection certification system developed by the Asia-Pacific Economic Cooperation (APEC). This achievement demonstrates Celltrion's commitment to enhancing shareholder value and promoting responsible management.

The company's efforts to enhance shareholder value have been fruitful, with a recorded 103% shareholder return rate in 2024. This has been achieved through a combination of cash dividends and treasury stock retirement, with a focus on acquiring and retiring treasury stock over the past three years. Celltrion's commitment to ESG management and responsible business practices is expected to continue, with the company aiming to sustain tangible results across its ESG efforts.

As the biopharmaceutical industry continues to evolve, companies like Celltrion are at the forefront of promoting sustainability and responsible management. The company's achievements in eco-friendly packaging, open innovation, and corporate governance serve as a model for other companies in the industry, highlighting the importance of ESG management in driving business success and promoting a better future for all stakeholders.

With its strong commitment to ESG management, Celltrion is well-positioned to continue making significant contributions to the biopharmaceutical industry, while also promoting sustainability and responsible business practices. As the company looks to the future, it is likely that its efforts in eco-friendly packaging, open innovation, and corporate governance will remain a key focus area, driving growth and success for both the company and its stakeholders.